Therapeutic plasma exchange in paediatric nephrology in Ireland
- PMID: 37940814
- DOI: 10.1007/s11845-023-03560-x
Therapeutic plasma exchange in paediatric nephrology in Ireland
Abstract
Background: Therapeutic plasma exchange (TPE) is utilised in the management of a limited number of paediatric renal conditions. Despite its widespread acceptance and advancements in the practice of apheresis, there remains a paucity of data pertaining to paediatrics. We present a large retrospective review of our cohort of paediatric patients undergoing TPE for renal indications, outlining their outcomes and complications.
Methods: A retrospective chart review was conducted for all patients (under 16 years) undergoing TPE for renal conditions between January 2002 and June 2019 in Ireland. Demographic and clinical data were extracted, with patients anonymised and stratified according to their pathology.
Results: A total of 58 patients were identified. A total of 1137 exchanges were performed using heparin sodium anticoagulation. The median age was 35.5 months (IQR 18-110 months). The leading indication was neurological involvement in Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS) (n = 29). Complications (minor or major) occurred in 65.5% (n = 38) of patients, with most experiencing minor complications 58.6% (n = 34). Asymptomatic hypocalcaemia was the most common complication in 43.1% (n = 25).
Conclusions: Our experience of TPE, spanning 1137 exchanges, proved a safe, well-tolerated therapy. Most complications were minor, and with therapy conducted in specialised centres, there are very low levels of adverse events.
Keywords: Nephrology; Paediatrics, Paediatric nephrology; Plasmapheresis; Therapeutic plasma exchange.
© 2023. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
References
-
- Reddy S, Jahan A, Chaturvedi S, Agarwal I (2015) Plasma exchange for paediatric kidney disease—indications and outcomes: a single-centre experience. Clin Kidney J 8(6):702–707. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655793/
-
- Schwab P, Fahey J (1960) Treatment of Waldenström’s macroglobulinemia by plasmapheresis. N Engl J Med 263(12):574–579. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1879704/
-
- Hans R, Sharma R, Marwaha N et al (2015) Efficacy and safety of therapeutic plasma exchange by using apheresis devices in pediatric atypical hemolytic uremic syndrome patients. J Clin Apher 31(4):381–387. Available from: https://pubmed.ncbi.nlm.nih.gov/26212115/
-
- Fencl F, Vondrak K, Rosik T et al (2016) Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis. Minerva Paediatr 68(5):348–354. Available from: https://pubmed.ncbi.nlm.nih.gov/26041001/
-
- Sartain S, Shubert S, Wu M, Srivaths P et al (2019) Therapeutic plasma exchange does not improve renal function in hematopoietic stem cell transplantation–associated thrombotic microangiopathy: an institutional experience. Biol Blood Marrow Transplant 25(1):157–162. Available from: https://pubmed.ncbi.nlm.nih.gov/30144562/
MeSH terms
LinkOut - more resources
Full Text Sources